JPMorgan International Research Enhanced Equity ETF (JIRE)
| Assets | $10.34B |
| Expense Ratio | 0.24% |
| PE Ratio | 18.20 |
| Shares Out | 127.28M |
| Dividend (ttm) | $2.24 |
| Dividend Yield | 2.75% |
| Ex-Dividend Date | Dec 16, 2025 |
| Payout Frequency | Annual |
| Payout Ratio | 50.13% |
| Volume | 490,498 |
| Open | 80.68 |
| Previous Close | 81.30 |
| Day's Range | 80.39 - 81.48 |
| 52-Week Low | 56.30 |
| 52-Week High | 81.96 |
| Beta | 0.85 |
| Holdings | 221 |
| Inception Date | Jun 10, 2022 |
About JIRE
Fund Home PageThe JPMorgan International Research Enhanced Equity ETF (JIRE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to stocks of any market capitalization from developed markets, excluding North America. JIRE was launched on Jun 10, 2022 and is issued by JPMorgan Chase.
Top 10 Holdings
16.82% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 3.07% |
| AstraZeneca PLC | AZN | 2.17% |
| Shell plc | SHEL | 1.70% |
| Siemens Aktiengesellschaft | SIE | 1.63% |
| Banco Santander, S.A. | SAN | 1.46% |
| Roche Holding AG | ROG | 1.42% |
| Nestlé S.A. | NESN | 1.39% |
| Safran SA | SAF | 1.37% |
| Allianz SE | ALV | 1.33% |
| Novartis AG | NOVN | 1.28% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $2.2393 | Dec 18, 2025 |
| Dec 24, 2024 | $1.77105 | Dec 27, 2024 |
| Dec 19, 2023 | $1.59913 | Dec 22, 2023 |
| Dec 20, 2022 | $1.31061 | Dec 23, 2022 |
Performance
JIRE had a total return of 30.71% in the past year, including dividends. Since the fund's inception, the average annual return has been 18.25%.
News
JPMorgan Adds International Equity ETF to Active Lineup
J.P. Morgan Asset Management launched the JPMorgan International Dynamic ETF (JIDE) Wednesday, adding an actively managed international equity strategy to a product lineup that has grown to see the fi...
3 ETFs for Diversifying Beyond AI
Avoid paying for the high expectations for AI stocks with these ETFs. Why the AI Spending Spree Could Spell Trouble for Investors,
JIRE: A Reasonable International Bet In An Unsure Domestic Economy
JPMorgan International Research Enhanced Equity ETF launched as an ETF in June 2022 after operating as a mutual fund. JIRE invests in developed markets, with a focus on financials, industrials, health...